WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO1999012559) INHIBITION OF APOPTOTIS USING PROSAPOSIN RECEPTOR AGONISTS
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/1999/012559    International Application No.:    PCT/US1998/019216
Publication Date: 18.03.1999 International Filing Date: 09.09.1998
Chapter 2 Demand Filed:    08.04.1999    
IPC:
A61K 38/18 (2006.01)
Applicants: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA [US/US]; 22nd floor 300 Lakeside Drive Oakland, CA 94612-3550 (US) (For All Designated States Except US).
O'BRIEN, John, S. [US/US]; (US) (For US Only)
Inventors: O'BRIEN, John, S.; (US)
Agent: WETHERELL, John, R., Jr.; Fish & Richardson P.C. Suite 1400 4225 Executive Square La Jolla, CA 92037 (US)
Priority Data:
60/058,352 09.09.1997 US
60/088,129 04.06.1998 US
Title (EN) INHIBITION OF APOPTOTIS USING PROSAPOSIN RECEPTOR AGONISTS
(FR) INHIBITION DE L'APOPTOSE AU MOYEN D'AGONISTES DU RECEPTEUR DE LA PROSAPOSINE
Abstract: front page image
(EN)A method for inhibiting caspase-mediated apoptosis by administering prosaposin receptor agonists is provided. Apoptosis has a major causative role in diseases such as rheumatoid arthritis, irritable bowel syndrome, congestive heart failure, multiple sclerosis, Alzheimer's disease, Parkinson's disease, myocardial infraction, and coronary ischemia.
(FR)L'invention concerne un procédé permettant d'inhiber l'apoptose liée à la caspase, par l'administration d'agonistes du récepteur de la prosaposine. L'apoptose constitue un facteur causal majeur dans des maladies telles que la polyarthrite rhumatoïde, le syndrome du côlon irritable, l'insuffisance cardiaque globale, la sclérose en plaques, la maladie d'Alzheimer, la maladie de Parkinson, l'infarctus du myocarde et l'ischémie coronarienne.
Designated States: AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, CA, CH, CN, CU, CZ, DE, DK, EE, ES, FI, GB, GE, GH, GM, HR, HU, ID, IL, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MD, MG, MK, MN, MW, MX, NO, NZ, PL, PT, RO, RU, SD, SE, SG, SI, SK, SL, TJ, TM, TR, TT, UA, UG, US, UZ, VN, YU, ZW.
African Regional Intellectual Property Organization (GH, GM, KE, LS, MW, SD, SZ, UG, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)